Progress in Mind Resource Centre Canada

On #WorldMentalHealthDay, we’re excited to announce the launch of our new bipolar disorder page on Progress in Mind Canada. Dive into the latest news, advancements, and expert insights in this critical area of mental health. Explore the page now to stay informed with cutting-edge content from leading Canadian and global key opinion leaders. Not registered yet? Sign up today to ensure you never miss out on educational and insightful updates, including key takeaways from major international congresses. https://bit.ly/4euhOx2 #progressinmindCA #bipolardisorder #brainhealth #WMHD

Social media platforms like TikTok have seen a rapid rise in popularity particularly among young people. While they provide an outlet for sharing experiences that can be inclusive and destigmatizing, they can also fuel a ‘sick-role subculture’ and have been linked to rising rates of self-diagnosis. The pros and cons of TikTok and its relation to mental health appropriation was the focus on a poster presented at the annual Canadian Psychiatric Association (CPA) conference in Vancouver in October, 2023. https://bit.ly/3TT2Lox #progressinmindCA #brainhealth #mentalhealth #socialmedia #selfdiagnosis

Clinical guidelines have an important role, particularly for those who may not treat a particular condition as often as an expert might. So how will updated migraine clinical guidelines impact clinical practice and improve patient outcomes in the management of migraine? As part of our ongoing migraine video series, Dr. William Kingston, Neurologist and Assistant Professor of Neurology at the University of Toronto, shares his perspective as someone deeply involved in migraine care in Canada. Watch the full video to learn more here: https://bit.ly/4gwrbxQ #progressinmindCA #migraine #brainhealth #WCN2023 #MHAM

Evidence suggests that up to 60% of patients taking antidepressants for major depressive disorder experience emotional blunting (the inability to feel emotions). Recent data from a multi-country survey points to a disconnect between patients’ and physicians’ perceptions on the prevalence, severity and impact of emotional blunting on people with major depression. Greater awareness of emotional blunting and its impact could help guide treatment pathways that help patients achieve full functional recovery.    Read more at the Progress in Mind Resource Centre Canada: https://bit.ly/3Zwl2vM #progressinmindCA #emotionalblunting #majordepressivedisorder #mdd #CINP2023

Non-pharmacological approaches are increasingly recognized as valuable in migraine management. How can pharmacists help patients with non-pharmacological strategies? As part of our migraine video series, Heba BaniHani BSc Pharm. MBA MHD, a Canadian Registered Pharmacist and migraine specialist, shares her insights and discusses how education is one aspect of migraine management that pharmacists can share with patients. Watch the full video to learn more: https://bit.ly/3zeRE2k #progressinmindCA #migraine #brainhealth #WCN2023 #MigraineAwareness #MigraineAdvocacy

The leading cause of death in patients with severe mental illness (SMI) is heart disease. The risk of heart failure among patients with SMI is double that of people without SMI. Patients with SMI do not receive the same treatment for atrial fibrillation, heart failure and heart attacks as people without SMI. Why are patients with SMI treated differently? Read more about these inequities and proposed solutions here: https://bit.ly/4fN4Zzl #progressinmindCA #SIRS2023 #schizophrenia #comorbidity #screening 

Migraine is often accompanied by mental health issues and healthcare providers play a crucial role in supporting patients dealing with comorbid migraine and mental illness. We spoke to Dr. William Kingston, Neurologist and Assistant Professor of Neurology at the University of Toronto, to find out his perspective on how HCPs can effectively counsel and support patients dealing with comorbid migraine and mental illness. Watch the full video to learn more here: https://bit.ly/4dOhQza #progressinmindCA #migraine #brainhealth #WCN2023 #MHAM 

At the 2024 Canadian Neurological Sciences Federation (CNSF) congress, Dr. William Kingston and Shawna Kelly presented a variety of topics, including the disease burden of migraine, factors that contribute to the chronification of migraine, various acute and preventive migraine treatments, the importance of patient counselling and treatment monitoring, and some practical advice for the management of migraine in special populations. https://bit.ly/3yIM0VR #progressinmindCA #brainhealth #cnsf #migraine

Clinicians could benefit from applying ‘a detective mindset’ when it comes to the diagnosis and management of co-occurring substance use disorders (SUD) and bipolar disorder. That was a key practical pearl shared by Dr. Joseph Goldberg, a Clinical Professor in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York, during a virtual educational webinar called “Improving the Lives of Patients with Bipolar Disorder” offered by the Neuroscience Education Institute (NEI). Read the full article on Progress in Mind Canada: https://bit.ly/4dlSTva   #progressinmindCA #brainhealth #mentalhealth #bipolardisorder #substanceuse

There has been a recent resurgence of clinical and research interest in hallucinogens for their potential to be used in psychedelic-assisted therapy for the treatment of people with severe psychiatric disorders. During the Family Medicine Forum 2023 in Montreal, Dr. Kathy Do, a family physician in North York, Ontario explained the history and evidence for this emerging treatment modality, and offered some practical insights into patient selection and how psychedelic-assisted therapy is delivered in the clinical context. Read more on Progress in Mind: https://bit.ly/3LTs4SZ #progressinmindCA #psychedelics #brainhealth #FMF2023